Avita Medical
RCEL
52 hedge funds and large institutions have $77.4M invested in Avita Medical in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
21% more funds holding
Funds holding: 43 → 52 (+9)
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
3.29% more ownership
Funds ownership: 15.99% → 19.28% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $86.7M → $77.4M (-$9.27M)
36% less call options, than puts
Call options by funds: $272K | Put options by funds: $425K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.43M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
+$3.04M |
| 3 |
Millennium Management
New York
|
+$2.07M |
| 4 |
CC
Clearline Capital
New York
|
+$1.99M |
| 5 |
Renaissance Technologies
New York
|
+$1.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Blackcrane Capital
Bellevue,
Washington
|
-$3.65M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$2.57M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$1.58M |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$697K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$169K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
APA
51
American Portfolios Advisors
Holbrook,
New York
| $780 | – | – | – |
|
|
SAM
52
Silvercrest Asset Management
New York
| – | -$2.57M | -102,236 | Closed |
|
|
PP
53
Paloma Partners
Greenwich,
Connecticut
| – | -$697K | -27,693 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | -$34.3K | -1,565 | Closed |
|
|
LFG
55
Larson Financial Group
St Louis,
Missouri
| – | -$2K | -64 | Closed |
|
RCEL Hedge Fund Activity: Q4 2020 in Review
52 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2020, worth a combined $77.4M — down 11% from $86.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RCEL positions and 4 closed out — a net gain of 9 holders — while 14 added to existing stakes and 12 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $6.43M. The largest seller was Blackcrane Capital, cutting an estimated $3.65M.
- 52 institutional investors held Avita Medical (RCEL) as of Q4 2020, up from 43 in Q3 2020.
- Funds reported $77.4M of Avita Medical stock for Q4 2020, down 11% quarter-over-quarter.
- 13 funds opened new Avita Medical positions in Q4 2020 and 4 closed out, a net change of +9 holders.
- The largest Avita Medical buyer in Q4 2020 was State Street, an estimated $6.43M added.
- The largest Avita Medical seller in Q4 2020 was Blackcrane Capital, an estimated $3.65M sold.
Based on aggregated 13F filings for Q4 2020.